TobaccoReporter logo

Blog

  • Minnesota AG Sues Local Company for Selling Flavored Vapes

    Minnesota AG Sues Local Company for Selling Flavored Vapes

    Minnesota AG Keith Ellison filed a lawsuit against local e-cigarette manufacturer Maduro Distributors, alleging the company sold banned flavored vape products under its The Loon brand that were marketed in ways appealing to youth. The complaint, filed in Ramsey County District Court, accuses the Fridley-based company of selling products with flavors including cotton candy and blue razz slushy, using “kid-friendly characters” in promotions, and falsely representing some products as FDA-approved.

    The Loon sells disposable and refillable vapes as well as nicotine pouches and previously received an FDA warning letter for marketing unauthorized products, according to The Minnesota Star Tribune. Maduro said it had changed flavor names before Minnesota’s 2024 ban took effect and removed the FDA approval claim from a third-party website, arguing it had cooperated with state officials.

  • Customs Joins Case Against Duty-Free Nicotine Sales in India

    Customs Joins Case Against Duty-Free Nicotine Sales in India

    India’s customs authorities joined the health ministry’s legal challenge against Adani Group’s sale of nicotine pouches at airport duty-free shops, arguing that duty-free status provides tax benefits but does not exempt retailers from broader regulatory requirements. In a filing to the Mumbai High Court, customs officials said goods being “outside customs frontiers” for taxation purposes do not grant immunity from other laws, rejecting Adani’s argument that international departure-area shops are beyond the reach of domestic regulations.

    The company has challenged a health ministry inspection that found nicotine pouch sales at Mumbai International Airport’s duty-free stores violated Indian law, arguing the products are legally sold under duty-free rules and sealed for use after passengers leave the country. The case is scheduled for its next hearing on July 28.

  • Cessation Trust Breaks from Health NZ Over Harm-Reduction Stance

    Cessation Trust Breaks from Health NZ Over Harm-Reduction Stance

    Wellington stop-smoking provider Takiri Mai Te Ata Trust ended its partnership with Health New Zealand after refusing to promote vaping as a smoking cessation tool. The trust, which has helped people quit smoking for more than 30 years, said it could not continue delivering services in a way that conflicted with its values. Regional manager Catherine Manning said the organization did not support helping people quit cigarettes by transitioning to another nicotine product.

    Health New Zealand said it worked extensively with the trust to find a solution that would allow the service to continue without directly supplying vapes, but no agreement was reached, and the contract ended by mutual consent. Health New Zealand maintains that vaping is less harmful than smoking and can help smokers quit, while stressing that non-smokers should not vape. Action for Smokefree 2025 director Ben Youdan said evidence shows vaping can be an effective cessation tool, adding that vaping is “not risk-free” but “dramatically” reduces the risk of death compared with smoking.

    Youdan said that while he recognized the trust’s concerns, many organizations have seen real benefits from using vaping as part of smoking cessation efforts.

  • Altria Schedules Financial Webcast for July 30

    Altria Schedules Financial Webcast for July 30

    Altria Group will host a live audio webcast on July 30 at 9 a.m. ET to discuss its 2026 second-quarter and first-half financial results, which will be released at approximately 7 a.m. ET that day. The webcast will feature Chief Executive Officer Sal Mancuso and Chief Financial Officer Heather Newman, who will review the company’s operating and financial performance and participate in a question-and-answer session with investors and the media. The event will be available in listen-only mode, with pre-registration required, and an archived replay will be posted on Altria’s investor relations website.

  • Alliance One’s New Seeds Transforming Tanzanian Yields

    Alliance One’s New Seeds Transforming Tanzanian Yields

    Tobacco farmers in Tanzania’s Tabora Region are reporting higher yields and improved incomes following the introduction of proprietary Alliance One Varieties (AOV) tobacco seeds by Alliance One Tobacco Tanzania Limited. Farmers said the new varieties, including AOV 212, AOV 405, and AOV 815, produce higher-quality leaf, offer greater resistance to disease and drought, and significantly outperform traditional seed varieties. According to growers, yields have increased from about 1,350 kg per hectare with conventional seeds to 3,000–3,500 kg per hectare with the new varieties.

    Alliance One said the seeds were developed through extensive research, with field trials conducted in collaboration with the Tanzania Tobacco Research Institute (TORITA), producing yields of more than 3,200 kg per hectare. Industry stakeholders said the improved seed varieties could strengthen Tanzania’s tobacco sector by boosting farm productivity, improving export-quality leaf, increasing grower incomes, and supporting higher agricultural export revenues. 

  • Switzerland Backs Cantons in Disposable Vape Ban

    Switzerland Backs Cantons in Disposable Vape Ban

    Switzerland’s Federal Court upheld the canton (state) of Valais’ ban on the sale of disposable e-cigarettes, dismissing legal challenges brought by the Swiss Tobacco Trade Association, Philip Morris Switzerland, and other parties. The ruling confirms that the ban, which took effect in May 2025 after being approved by the canton’s parliament in 2024, is compatible with federal law and serves legitimate public health and environmental objectives.

    The court found that while the federal government has the authority to prohibit disposable e-cigarettes nationwide, individual cantons may enact their own restrictions until such action is taken at the national level.

  • VB Distribution Expands Ahead of UK’s Vape Duty Change

    VB Distribution Expands Ahead of UK’s Vape Duty Change

    VB Distribution announced the opening of a new 100,000-square-foot business park in Lancashire, England, expanding its national warehousing network to 500,000 square feet and strengthening its customs bonded storage capacity ahead of the U.K.’s Vaping Products Duty, which takes effect on Oct. 1. The company said the HMRC-approved bonded warehouse will allow duty-suspended storage, helping retailers better manage inventory and cash flow as the new tax is implemented.

    Company CEO Natalia Gosciniak said the investment positions VB Distribution to provide compliant stock and supply continuity, alleviating cost pressures faced by smaller distributors without bonded infrastructure. VB Distribution, which supplies more than 50,000 retail shelf placements across the U.K. and reports an annual turnover of £500 million, said the facility is fully operational and could create up to 1,000 jobs as part of its broader expansion strategy.

  • Macau Moves Toward Tighter Nicotine Controls

    Macau Moves Toward Tighter Nicotine Controls

    Macau’s Legislative Assembly’s Third Standing Committee completed its review of amendments to the city’s tobacco law and endorsed the government’s proposals ahead of a final legislative vote, moving it closer to adopting stricter tobacco controls. The bill would expand smoke-free zones to within 10 meters of hospitals, health centers, and schools; prohibit the possession or use of e-cigarettes in smoke-free and certain public outdoor areas; and ban the manufacture, sale, import, and export of nicotine pouches, herbal cigarettes, and hookahs. It also raises fines for illegally transporting these products across Macau’s borders from MOP4,000 to MOP10,000 ($480 to $1,200), while requiring cigar packaging to carry health warnings covering 70% of both sides.

    If approved, most provisions would take effect on Jan. 1, 2027, with standardized tobacco packaging and expanded warning labels phased in beginning July 1, 2028.

  • Former CTP Toxicologist Accuses FDA of Approving Zyn Without Full Facts

    Former CTP Toxicologist Accuses FDA of Approving Zyn Without Full Facts

    A report published yesterday (July 14) by The Examination and STAT raised questions about the U.S. Food and Drug Administration’s review process for Philip Morris International’s Zyn nicotine pouches, alleging that agency scientists had unresolved concerns about the composition and potential health implications of the pouch material before the product was authorized for sale. The report said FDA toxicologist Christy Leppanen questioned whether regulators had adequately assessed possible microplastic exposure after conducting informal tests that found Zyn pouches did not dissolve when exposed to saliva or other conditions. Leppanen alleged that the FDA did not seek additional information from PMI about the pouch material before approving the product, while former FDA officials cited in the report questioned whether the agency fully evaluated all product components as required under federal law.

    The allegations come as nicotine pouches have become one of the fastest-growing segments of the tobacco and nicotine market. The U.S. nicotine pouch market is estimated to grow 37% in 2026 to $6.8 billion, according to TobaccoIntelligence, with companies promoting pouches as lower-risk alternatives to combustible cigarettes because they deliver nicotine without smoke exposure. The FDA has authorized certain nicotine pouches, including Zyn, based on a review of whether the products are appropriate for the protection of public health, weighing potential risks such as youth uptake against potential benefits for adult smokers transitioning away from cigarettes. PMI defended the authorization process, citing the FDA’s scientific review, while the FDA said its evaluation did not identify additional concerns regarding the ingredients or materials used in Zyn products. Concerns raised by Leppanen and other scientists center on whether pouch materials could release microscopic particles during use and what long-term effects those exposures may have. The FDA’s recent decision allowing PMI to communicate that Zyn use instead of cigarettes lowers the risk of certain smoking-related diseases represented a major regulatory milestone for the category, but, according to The Examination, the allegations in the report may fuel additional debate over product standards, disclosure requirements, and the depth of scientific reviews for emerging nicotine products.

  • Public Health Groups Sueing FDA Over New Vape, Pouch Stance

    Public Health Groups Sueing FDA Over New Vape, Pouch Stance

    A coalition of public health organizations, including the Campaign for Tobacco-Free Kids, American Academy of Pediatrics, American Heart Association, and American Lung Association, filed a federal lawsuit yesterday (July 14) challenging the U.S. Food and Drug Administration’s May 2026 enforcement guidance for e-cigarettes and nicotine pouches. The plaintiffs argue the policy unlawfully allows unauthorized products to remain on the market without the premarket scientific review required under the Tobacco Control Act, creating an enforcement safe-harbor for products that FDA has previously identified as posing significant youth appeal.

    Filed in the U.S. District Court for the District of Maryland, the lawsuit seeks to overturn the guidance, alleging it violates both the Tobacco Control Act and the Administrative Procedure Act, and could have significant implications for manufacturers and retailers by determining whether products with pending marketing applications can continue to be sold while awaiting FDA review.